Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Hyderabad-pharma"

2 News Found

Telangana life sciences ecosystem reaches $145 billion valuation
Biotech | May 15, 2026

Telangana life sciences ecosystem reaches $145 billion valuation

The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Biopharma | May 01, 2026

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Strong CDMO growth, improved product mix and operational leverage drive profitability expansion

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

T-CURX gets Swissmedic nod for first human trial of non-viral CAR-T therapy

Ramkrishna CARE Hospitals’s dedicated cancer institute to open in August 2026

India-France Innovation Roadmap 2030 opens fresh opportunities for pharma and healthcare

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
Our D2 lamp portfolio caters to entire spectrum of chromatography and spectroscopy customers: Hemang Jhaveri, Partner, Hiten Techno Products Corporation
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
From bench to work flow, we are an integrated solution provider: K.O. Satish, Associate Vice President, Spinco Biotech
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Our vision is to make genomics as commonplace as BP monitor: Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences
Dr. Ramesh Hariharan Chief Executive Officer, Strand Life Sciences

Packaging